Buteyko Breathing and Approach of Smoking Hygiene: Effects on Dysfucntion of Eustachian Tube and Lung Functions

November 15, 2025 updated by: Ali Mohamed Ali ismail, Cairo University

Is There Efficacy of Adding Buteyko Breathing to Approach of Smoking Hygiene on Dysfucntion of Eustachian Tube and Lung Functions in Adolescnets Who Are Passively Exposed to Tobacco Smoke?

adolescents are usually exposed to tobacco smoke passively. this can reduce their lung functions and negatively impact functions of Eustachian tube. The solution is to lower rates to tobacco exposure and use the support of Buteyko Breathing

Study Overview

Detailed Description

in this study, we will randolmly recruit 40 adolescents who are usually exposed to tobacco smoke passively in house from smoking parent or household members. these adolescents will complain chronic dysfunction of their Eustachian Tube (chronic obstructive dysfucntion) . adolescents will be catagorized to one of both groupsl, group I or group II (N=20 patient in the group). Both groups will receive smokinh hyeigne approach for 6 months. Group I will additionally receive Buteyko Breathing 30-minute apprach (this appraoch will be appleid by patients all days, except fridays, weekly for 6 months).

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Dokki
      • Giza, Dokki, Egypt
        • Recruiting
        • Cairo University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Dysfucntion of Eustachian Tube (obstructive chronic form)
  • adolescents with passive tobacco exposure from smoking parent or household member
  • adolscent participants whose parents approve the participation

Exclusion Criteria:

  • cardiac problem
  • chest disease
  • renal/hepatic disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: group number 1
in this group, we will include 20 adolescents who are usually exposed to tobacco smoke passively in house from smoking parent or household members. these adolescents will complain chronic dysfunction of their Eustachian Tube (chronic obstructive dysfucntion) . adolescents will receive smoking hyeigne approach for 6 months.This group will additionally receive Buteyko Breathing 30-minute apprach (this appraoch will be appleid by patients all days weekly, except fridays, for 6 months).
in this group, we will include 20 adolescents who are usually exposed to tobacco smoke passively in house from smoking parent or household members. these adolescents will complain chronic dysfunction of their Eustachian Tube (chronic obstructive dysfucntion) . adolescents will receive smoking hyeigne approach for 6 months.This group will additionally receive Buteyko Breathing 30-minute apprach (this appraoch will be appleid by patients all days weekly, except fridays, for 6 months).
Active Comparator: group number 2
in this group, we will include 20 adolescents who are usually exposed to tobacco smoke passively in house from smoking parent or household members. these adolescents will complain chronic dysfunction of their Eustachian Tube (chronic obstructive dysfucntion) . adolescents will receive smoking hyeigne approach for 6 months.
in this group, we will include 20 adolescents who are usually exposed to tobacco smoke passively in house from smoking parent or household members. these adolescents will complain chronic dysfunction of their Eustachian Tube (chronic obstructive dysfucntion) . adolescents will receive smoking hyeigne approach for 6 months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Eustachian Tube dyafucntion questionaire
Time Frame: it will be measured after 6 months
it is a questionaire contain 7 items
it will be measured after 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
percentage of change in type of tympanmetery
Time Frame: it will be measured after 6 months
it will assess percenatge of type c tympanometry
it will be measured after 6 months
forced vital capcity
Time Frame: it will be measured after 6 months
it is a pulmaonry fucntion test
it will be measured after 6 months
force expiratory volume (FEV1)
Time Frame: it will be measured after 6 months
it will be mesured in the first second of expiration as a pulmaonry fucntion test
it will be measured after 6 months
FEV1/FVC
Time Frame: it will be measured after 6 monthd
it is a pulmaonry fucntion test
it will be measured after 6 monthd
physical summary of parent form child health questinaire
Time Frame: it will be measured after 6 months
it will assess quality of life
it will be measured after 6 months
mental summary of parent form child health questinaire
Time Frame: it will be measured after 6 months
it will assess quality of life
it will be measured after 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ali MA Ismail, lecturer, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 15, 2026

Study Registration Dates

First Submitted

November 15, 2025

First Submitted That Met QC Criteria

November 15, 2025

First Posted (Actual)

November 19, 2025

Study Record Updates

Last Update Posted (Actual)

November 19, 2025

Last Update Submitted That Met QC Criteria

November 15, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB00014233-50

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tobacco Smoking

Subscribe